Literature DB >> 2184052

[The use of the antipyrine test for studying microsomal drug oxidation].

A P Viktorov, A T Rybak.   

Abstract

The data about the use of "antipyrine test" in clinical practice for studying the drug oxidation peculiarities are presented. The data characterize the main pharmacokinetic properties of antipyrine as a "metabolic marker" for quantitative estimation of the effects of inductors and inhibitors on the liver microsomal enzyme activity. The research methods are described and the data on the effects of different environmental factors on antipyrine metabolism are presented. The peculiarities of using the drug as a model for studying the effects of different environmental factors on the drug metabolism are formulated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184052

Source DB:  PubMed          Journal:  Farmakol Toksikol        ISSN: 0014-8318


  1 in total

1.  Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction.

Authors:  J Wójcicki; T Sulikowski; M Wójcicki; M Droździk; B Gawrońska-Szklarz; B Barcew-Wiszniewska; J Skowron; L Rózewicka
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.